Canopy Growth Completes Acquisition of Pharmaceutical Research Arm

0
161

Visit the Canopy Growth Corp Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors. TORONTO and SMITHS FALLS, ON, Aug. 7, 2018 /PRNewswire/ – Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (“Canopy Growth” or the “Company”) is pleased to announce that it has completed the previously announced acquisition of Canopy Health Innovations Inc. (“CHI”), including the subsidiary operations of Canopy Animal Health Inc. (“CAH”). The Company believes its strategy of integrating and aligning CHI’s clinical platform with the international work of Spectrum Cannabis, will accelerate its comprehensive research programs, build evidence around Canopy products and formulations and ultimately improve patient access to medical cannabis globally. Canopy Growth Completes Acquisition of Pharmaceutical Research Arm

thumbnail courtesy of newcannabisventures.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here